Compare Stocks

2 / 10
Try these comparisons:

Stock Comparison

CNS vs VRTS

Revenue, margins, valuation, and 5-year total return — side by side.

Live fundamentals10-year financials5-year price chart
CNS
Cohen & Steers, Inc.

Asset Management

Financial ServicesNYSE • US
Market Cap$3.60B
5Y Perf.+11.0%
VRTS
Virtus Investment Partners, Inc.

Asset Management

Financial ServicesNASDAQ • US
Market Cap$960M
5Y Perf.+54.2%

CNS vs VRTS — Key Financials

Market cap, revenue, margins, and valuation side-by-side.

Company Snapshot
CNS logoCNS
VRTS logoVRTS
IndustryAsset ManagementAsset Management
Market Cap$3.60B$960M
Revenue (TTM)$517M$831M
Net Income (TTM)$164M$138M
Gross Margin46.8%74.9%
Operating Margin33.4%17.4%
Forward P/E20.6x5.6x
Total Debt$141M$2.84B
Cash & Equiv.$183M$477M

CNS vs VRTSLong-Term Stock Performance

Price return indexed to 100 at period start. Dividends excluded.

CNS
VRTS
StockMay 20May 26Return
Cohen & Steers, Inc. (CNS)100111.0+11.0%
Virtus Investment P… (VRTS)100154.2+54.2%

Price return only. Dividends and distributions are not included.

Quick Verdict: CNS vs VRTS

Each card shows where this stock fits in a portfolio — not just who wins on paper.

Bottom line: CNS leads in 4 of 7 categories, making it the strongest pick for growth and revenue expansion and profitability and margin quality. Virtus Investment Partners, Inc. is the stronger pick specifically for valuation and capital efficiency and dividend income and shareholder returns. As sector peers, any of these can serve as alternatives in the same allocation.
CNS
Cohen & Steers, Inc.
The Banking Pick

CNS carries the broadest edge in this set and is the clearest fit for growth exposure and sleep-well-at-night.

  • Rev growth 5.7%, EPS growth 14.2%
  • Lower volatility, beta 0.98, Low D/E 24.5%, current ratio 25.39x
  • Beta 0.98, yield 3.3%, current ratio 25.39x
Best for: growth exposure and sleep-well-at-night
VRTS
Virtus Investment Partners, Inc.
The Banking Pick

VRTS is the clearest fit if your priority is income & stability and long-term compounding.

  • Dividend streak 7 yrs, beta 1.14, yield 6.5%
  • 159.1% 10Y total return vs CNS's 151.0%
  • PEG 0.38 vs CNS's 16.39
Best for: income & stability and long-term compounding
See the full category breakdown
CategoryWinnerWhy
GrowthCNS logoCNS5.7% NII/revenue growth vs VRTS's -8.0%
ValueVRTS logoVRTSLower P/E (5.6x vs 20.6x), PEG 0.38 vs 16.39
Quality / MarginsCNS logoCNSEfficiency ratio 0.1% vs VRTS's 0.6% (lower = leaner)
Stability / SafetyCNS logoCNSBeta 0.98 vs VRTS's 1.14, lower leverage
DividendsVRTS logoVRTS6.5% yield, 7-year raise streak, vs CNS's 3.3%
Momentum (1Y)VRTS logoVRTS-4.2% vs CNS's -5.1%
Efficiency (ROA)CNS logoCNSEfficiency ratio 0.1% vs VRTS's 0.6%

CNS vs VRTS — Revenue Breakdown by Segment

How each company's revenue is distributed across its business units

CNSCohen & Steers, Inc.
FY 2024
Open-End Investment Funds
55.7%$288M
Institutional Accounts
24.9%$129M
Closed-End Investment Funds
19.3%$100M
VRTSVirtus Investment Partners, Inc.
FY 2025
Investment Management Fees
50.0%$725M
Open End Funds
19.8%$287M
Retail Separate Accounts
14.5%$210M
Institutional Accounts
11.6%$168M
Closed End Funds
4.2%$61M

CNS vs VRTS — Financial Metrics

Side-by-side numbers across 2 stocks — who leads on profitability, valuation, growth, and risk.

BEST OVERALLCNSLAGGINGVRTS

Income & Cash Flow (Last 12 Months)

CNS leads this category, winning 3 of 5 comparable metrics.

VRTS is the larger business by revenue, generating $831M annually — 1.6x CNS's $517M. CNS is the more profitable business, keeping 29.2% of every revenue dollar as net income compared to VRTS's 16.7%.

MetricCNS logoCNSCohen & Steers, I…VRTS logoVRTSVirtus Investment…
RevenueTrailing 12 months$517M$831M
EBITDAEarnings before interest/tax$198M$205M
Net IncomeAfter-tax profit$164M$138M
Free Cash FlowCash after capex-$94M-$67M
Gross MarginGross profit ÷ Revenue+46.8%+74.9%
Operating MarginEBIT ÷ Revenue+33.4%+17.4%
Net MarginNet income ÷ Revenue+29.2%+16.7%
FCF MarginFCF ÷ Revenue+16.4%-8.9%
Rev. Growth (YoY)Latest quarter vs prior year
EPS Growth (YoY)Latest quarter vs prior year+5.2%+10.9%
CNS leads this category, winning 3 of 5 comparable metrics.

Valuation Metrics

VRTS leads this category, winning 6 of 6 comparable metrics.

At 7.2x trailing earnings, VRTS trades at a 70% valuation discount to CNS's 23.8x P/E. Adjusting for growth (PEG ratio), VRTS offers better value at 0.49x vs CNS's 18.88x — a lower PEG means you pay less per unit of expected earnings growth.

MetricCNS logoCNSCohen & Steers, I…VRTS logoVRTSVirtus Investment…
Market CapShares × price$3.6B$960M
Enterprise ValueMkt cap + debt − cash$3.6B$3.3B
Trailing P/EPrice ÷ TTM EPS23.75x7.18x
Forward P/EPrice ÷ next-FY EPS est.20.63x5.61x
PEG RatioP/E ÷ EPS growth rate18.88x0.49x
EV / EBITDAEnterprise value multiple19.32x16.25x
Price / SalesMarket cap ÷ Revenue6.95x1.16x
Price / BookPrice ÷ Book value/share6.25x0.96x
Price / FCFMarket cap ÷ FCF42.31x
VRTS leads this category, winning 6 of 6 comparable metrics.

Profitability & Efficiency

CNS leads this category, winning 7 of 7 comparable metrics.

CNS delivers a 28.3% return on equity — every $100 of shareholder capital generates $28 in annual profit, vs $14 for VRTS. CNS carries lower financial leverage with a 0.25x debt-to-equity ratio, signaling a more conservative balance sheet compared to VRTS's 2.74x.

MetricCNS logoCNSCohen & Steers, I…VRTS logoVRTSVirtus Investment…
ROE (TTM)Return on equity+28.3%+13.5%
ROA (TTM)Return on assets+20.5%+3.6%
ROICReturn on invested capital+19.2%+3.0%
ROCEReturn on capital employed+22.8%+3.7%
Piotroski ScoreFundamental quality 0–955
Debt / EquityFinancial leverage0.25x2.74x
Net DebtTotal debt minus cash-$42M$2.4B
Cash & Equiv.Liquid assets$183M$477M
Total DebtShort + long-term debt$141M$2.8B
Interest CoverageEBIT ÷ Interest expense2.15x
CNS leads this category, winning 7 of 7 comparable metrics.

Total Returns (Dividends Reinvested)

CNS leads this category, winning 4 of 6 comparable metrics.

A $10,000 investment in CNS five years ago would be worth $11,859 today (with dividends reinvested), compared to $6,525 for VRTS. Over the past 12 months, VRTS leads with a -4.2% total return vs CNS's -5.1%. The 3-year compound annual growth rate (CAGR) favors CNS at 12.7% vs VRTS's 0.4% — a key indicator of consistent wealth creation.

MetricCNS logoCNSCohen & Steers, I…VRTS logoVRTSVirtus Investment…
YTD ReturnYear-to-date+12.0%-8.8%
1-Year ReturnPast 12 months-5.1%-4.2%
3-Year ReturnCumulative with dividends+43.2%+1.1%
5-Year ReturnCumulative with dividends+18.6%-34.8%
10-Year ReturnCumulative with dividends+151.0%+159.1%
CAGR (3Y)Annualised 3-year return+12.7%+0.4%
CNS leads this category, winning 4 of 6 comparable metrics.

Risk & Volatility

CNS leads this category, winning 2 of 2 comparable metrics.

CNS is the less volatile stock with a 0.98 beta — it tends to amplify market swings less than VRTS's 1.14 beta. A beta below 1.0 means the stock typically moves less than the S&P 500. CNS currently trades 84.0% from its 52-week high vs VRTS's 66.7% drawdown — a narrower gap to the peak suggests stronger recent price momentum.

MetricCNS logoCNSCohen & Steers, I…VRTS logoVRTSVirtus Investment…
Beta (5Y)Sensitivity to S&P 5000.98x1.14x
52-Week HighHighest price in past year$83.99$215.06
52-Week LowLowest price in past year$58.39$121.61
% of 52W HighCurrent price vs 52-week peak+84.0%+66.7%
RSI (14)Momentum oscillator 0–10060.355.1
Avg Volume (50D)Average daily shares traded322K100K
CNS leads this category, winning 2 of 2 comparable metrics.

Analyst Outlook

VRTS leads this category, winning 2 of 2 comparable metrics.

Wall Street rates CNS as "Sell" and VRTS as "Hold". Consensus price targets imply 13.7% upside for VRTS (target: $163) vs 7.7% for CNS (target: $76). For income investors, VRTS offers the higher dividend yield at 6.50% vs CNS's 3.32%.

MetricCNS logoCNSCohen & Steers, I…VRTS logoVRTSVirtus Investment…
Analyst RatingConsensus buy/hold/sellSellHold
Price TargetConsensus 12-month target$76.00$163.00
# AnalystsCovering analysts1311
Dividend YieldAnnual dividend ÷ price+3.3%+6.5%
Dividend StreakConsecutive years of raises27
Dividend / ShareAnnual DPS$2.34$9.32
Buyback YieldShare repurchases ÷ mkt cap+0.6%+6.2%
VRTS leads this category, winning 2 of 2 comparable metrics.
Key Takeaway

CNS leads in 4 of 6 categories (Income & Cash Flow, Profitability & Efficiency). VRTS leads in 2 (Valuation Metrics, Analyst Outlook).

Best OverallCohen & Steers, Inc. (CNS)Leads 4 of 6 categories
Loading custom metrics...

CNS vs VRTS: Frequently Asked Questions

10 questions · data-driven answers · updated daily

01

Is CNS or VRTS a better buy right now?

For growth investors, Cohen & Steers, Inc.

(CNS) is the stronger pick with 5. 7% revenue growth year-over-year, versus -8. 0% for Virtus Investment Partners, Inc. (VRTS). Virtus Investment Partners, Inc. (VRTS) offers the better valuation at 7. 2x trailing P/E (5. 6x forward), making it the more compelling value choice. Analysts rate Virtus Investment Partners, Inc. (VRTS) a "Hold" — based on 11 analyst ratings — the highest consensus in this comparison. The "better buy" depends entirely on your goals: growth investors should weight revenue trajectory, value investors should weight P/E and PEG, and income investors should weight dividend yield and streak.

02

Which has the better valuation — CNS or VRTS?

On trailing P/E, Virtus Investment Partners, Inc.

(VRTS) is the cheapest at 7. 2x versus Cohen & Steers, Inc. at 23. 8x. On forward P/E, Virtus Investment Partners, Inc. is actually cheaper at 5. 6x. The PEG ratio (P/E divided by earnings growth rate) is the most growth-adjusted single valuation metric: Virtus Investment Partners, Inc. wins at 0. 38x versus Cohen & Steers, Inc. 's 16. 39x — a PEG below 1. 0 traditionally signals the market is underpricing earnings growth.

03

Which is the better long-term investment — CNS or VRTS?

Over the past 5 years, Cohen & Steers, Inc.

(CNS) delivered a total return of +18. 6%, compared to -34. 8% for Virtus Investment Partners, Inc. (VRTS). Over 10 years, the gap is even starker: VRTS returned +159. 1% versus CNS's +151. 0%. Past returns do not guarantee future results, and the stock with the higher historical return may already have its best growth priced in.

04

Which is safer — CNS or VRTS?

By beta (market sensitivity over 5 years), Cohen & Steers, Inc.

(CNS) is the lower-risk stock at 0. 98β versus Virtus Investment Partners, Inc. 's 1. 14β — meaning VRTS is approximately 16% more volatile than CNS relative to the S&P 500. On balance sheet safety, Cohen & Steers, Inc. (CNS) carries a lower debt/equity ratio of 25% versus 3% for Virtus Investment Partners, Inc. — giving it more financial flexibility in a downturn.

05

Which is growing faster — CNS or VRTS?

By revenue growth (latest reported year), Cohen & Steers, Inc.

(CNS) is pulling ahead at 5. 7% versus -8. 0% for Virtus Investment Partners, Inc. (VRTS). On earnings-per-share growth, the picture is similar: Virtus Investment Partners, Inc. grew EPS 18. 2% year-over-year, compared to 14. 2% for Cohen & Steers, Inc.. Higher growth typically commands a higher valuation multiple — check whether the premium P/E or P/S is justified by the growth rate using the PEG ratio.

06

Which has better profit margins — CNS or VRTS?

Cohen & Steers, Inc.

(CNS) is the more profitable company, earning 29. 2% net margin versus 16. 7% for Virtus Investment Partners, Inc. — meaning it keeps 29. 2% of every revenue dollar as bottom-line profit. Operating margin tells a similar story: CNS leads at 33. 4% versus 17. 4% for VRTS. At the gross margin level — before operating expenses — VRTS leads at 74. 9%, reflecting greater pricing power or product mix advantage. Stronger margins indicate durable pricing power, lower cost of revenue, or higher mix of software/services. They are one of the clearest signs of business quality.

07

Is CNS or VRTS more undervalued right now?

The PEG ratio (forward P/E divided by expected earnings growth rate) is the most precise measure of undervaluation relative to growth potential.

By this metric, Virtus Investment Partners, Inc. (VRTS) is the more undervalued stock at a PEG of 0. 38x versus Cohen & Steers, Inc. 's 16. 39x. A PEG below 1. 0 is traditionally considered the threshold for growth-adjusted undervaluation. On forward earnings alone, Virtus Investment Partners, Inc. (VRTS) trades at 5. 6x forward P/E versus 20. 6x for Cohen & Steers, Inc. — 15. 0x cheaper on a one-year earnings basis. Analyst consensus price targets imply the most upside for VRTS: 13. 7% to $163. 00.

08

Which pays a better dividend — CNS or VRTS?

All stocks in this comparison pay dividends.

Virtus Investment Partners, Inc. (VRTS) offers the highest yield at 6. 5%, versus 3. 3% for Cohen & Steers, Inc. (CNS).

09

Is CNS or VRTS better for a retirement portfolio?

For long-horizon retirement investors, Cohen & Steers, Inc.

(CNS) is the stronger choice — it scores higher on the combination of lower volatility, dividend reliability, and long-term compounding (low volatility (β 0. 98), 3. 3% yield, +151. 0% 10Y return). Both have compounded well over 10 years (CNS: +151. 0%, VRTS: +159. 1%), confirming both are viable long-term holds — but the lower-volatility option typically results in less emotional selling during corrections. Retirement portfolios generally favour predictability over maximum returns. Consult a financial advisor before making allocation decisions.

10

What are the main differences between CNS and VRTS?

Both stocks operate in the Financial Services sector, making this a peer-level intra-sector comparison — the same macro tailwinds and headwinds will affect both.

In terms of investment character: CNS is a small-cap income-oriented stock; VRTS is a small-cap deep-value stock. These fundamental differences mean investors should not choose between them on a single metric — the "better stock" depends entirely on which of these characteristics aligns with your investment strategy.

Find Stocks Like These

Explore pre-built screens for each stock's profile, or build a custom screen to find stocks that outperform both.

Stocks Like

CNS

Dividend Mega-Cap Quality

  • Sector: Financial Services
  • Market Cap > $100B
  • Revenue Growth > 5%
  • Net Margin > 17%
Run This Screen
Stocks Like

VRTS

Income & Dividend Stock

  • Sector: Financial Services
  • Market Cap > $100B
  • Net Margin > 9%
  • Dividend Yield > 2.6%
Run This Screen
Custom Screen

Beat Both

Find stocks that outperform CNS and VRTS on the metrics below

Revenue Growth>
%
(CNS: 5.7% · VRTS: -8.0%)
Net Margin>
%
(CNS: 29.2% · VRTS: 16.7%)
P/E Ratio<
x
(CNS: 23.8x · VRTS: 7.2x)

You Might Also Compare

Based on how these companies actually compete and overlap — not just which sector they're filed under.